APA (7th ed.) Citation

Dimou, M., Fioretzaki, R., Zerzi, C., Konstantinou, E., Asimakopoulos, J. V., Arapaki, M., . . . Panayiotidis, P. (2025). Venetoclax–Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview. Cancers, 17(19), 3159. https://doi.org/10.3390/cancers17193159

Chicago Style (17th ed.) Citation

Dimou, Maria, et al. "Venetoclax–Rituximab and Emerging Treatment Strategies After C-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview." Cancers 17, no. 19 (2025): 3159. https://doi.org/10.3390/cancers17193159.

MLA (9th ed.) Citation

Dimou, Maria, et al. "Venetoclax–Rituximab and Emerging Treatment Strategies After C-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview." Cancers, vol. 17, no. 19, 2025, p. 3159, https://doi.org/10.3390/cancers17193159.